USE OF ANTITHROMBIN IN EXTRACORPOREAL MEMBRANE OXYGENATION
First Claim
Patent Images
1. A method of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation, the method comprising:
- administering to a subject having extracorporeal membrane oxygenation a therapeutically effective amount of antithrombin to suppress blood clotting and/or prevent hemorrhage.
1 Assignment
0 Petitions
Accused Products
Abstract
In one aspect, the disclosure provides methods of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation comprising administering antithrombin. In some embodiments, the antithrombin used in the methods disclosed herein is ATryn®.
-
Citations
14 Claims
-
1. A method of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation, the method comprising:
administering to a subject having extracorporeal membrane oxygenation a therapeutically effective amount of antithrombin to suppress blood clotting and/or prevent hemorrhage. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
Specification